Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 211   

Articles published

VRX 14.39 +0.05 (0.35%)
price chart
Valeant Pharmaceuticals Intl Inc.: Still a Risk or on the Way up?
It may take another few years before analysts and investors stop talking about Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as a colossal risk and instead talk about it as a major opportunity.
The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak  Investorplace.com
Hold Valeant Stock And Plug Power, Buy MannKind Corporation Stock - Top ...  Amigobulls
Why an Investment in Valeant Pharmaceuticals Intl Inc. Needs to Be Long Term
A lot of ado has been made about the impressive debt-repayment initiatives put in place by Valeant Pharmaceuticals Intl Inc.'s (TSX:VRX)(NYSE:VRX) management team, headquartered by CEO Joseph Papa. The once-shining example of a pharmaceutical ...
Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win  Investorplace.com
Valeant Pharmaceuticals International, Inc. (VRX) Sentiment Based on the ...  StockNewsGazette
Why Valeant Pharmaceuticals Intl Inc. Dropping Is of Little Consequence
The beleaguered pharmaceutical giant tumbled again recently, sinking as much as 10%, with the stock price sinking once again below $20.
Valeant cuts revenue forecast; progresses on debt repayment  BNN
Valeant Pharmaceuticals Intl Inc Q2 2017 Earnings Boost Shares  ValueWalk
Long-Term Investors: Buy the Dip With Valeant Pharmaceuticals Intl Inc.
The reaction an investor gets when they hear about Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) tends to be mixed, to say the least.
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Shares Sold by TD ...  Week Herald
Piper Jaffray Companies Reiterates “$14.00” Price Target for Valeant ...  Sports Perspectives
Valeant Pharmaceutical Intl Inc. Is Back on the Growth Track: Time to Buy?
Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) took a 9.57% plunge on Wednesday following a rally over 10% in response to a solid earnings beat.
Valeant Pharmaceuticals Stock Gains Short Lived Post Q2 Financial Results  SmallCapPower (press release)
Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy  Canada NewsWire (press release)
Could Valeant Pharmaceutical Intl Inc. Hit $30?
Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) is looking like a suitable long-term investment again thanks to the new CEO Joseph Papa, who has been steadily cutting down the debt and cleaning up the mess that ex-CEO Michael Pearson made ...
Guardian Capital LP Upped Oracle (ORCL) Stake; As Valeant Pharmaceuticals ...  BZ Weekly
EPS for Valeant Pharmaceuticals Intl Inc (VRX) Expected At $1.18  Finance News Daily
Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group ...
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen its stock tumble 30% in the past year, and over five years, the stock has declined by over 58%.
First Impression of 2 Faltering Biotech Stocks: Valeant Pharmaceuticals Intl ...  Smarter Analyst
Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI ...
LAVAL, Quebec, Aug. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the U.S.
Valeant Pharma works to resolve FDA concerns at Tampa plant  MarketWatch
Valeant says FDA to reclassify troubled Tampa plant  BioPharma Dive
Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for ...
LAVAL, Quebec, Aug. 7, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has received a Complete Response Letter (CRL) from the U.S.
Valeant Pharmaceuticals Intl Inc: FDA Issues Complete Response Letter on ...  Smarter Analyst
Press Release concerning latanoprostene bunod ophthalmic solution, 0.024%  GlobeNewswire (press release)
Francis Chou Buys Valeant Pharmaceuticals International Inc, Teva ...
Francis Chou added to the holdings in Valeant Pharmaceuticals International Inc by 29.74%. The purchase prices were between $8.51 and $17.31, with an estimated average price of $11.95.